- AGN Ticker
- 🇺🇸 NYSE Exchange
- 16,900 Employees
- 💊 Health Care Sector
- 👩🏻⚕ Pharmaceuticals Industry
- Brenton L. Saunders CEO
Analyst Recommendations
This chart is a recommendation for investors. To provide forecasts, analysts and brokers use companies' public financial reports and speak with their employees and clients. The end result is a solution that's marked on the chart, which shows analysts' opinions at different periods of time. Move your cursor to track on what the dates the recommendations changed.
Investors shouldn't only follow analyst recommendations. Forecasts should be used to supplement existing strategies and plans. Trading based on a recommendation chart is is considered bad practice. Analyst reports should only be used in conjunction with your own analytics.
Also known as strong sell, it's a recommendation to sell a security or to liquidate an asset.
A recommendation that means a stock is expected to do slightly worse than the overall stock market return. Underperform can also be expressed as "moderate sell", "weak hold" and "underweight."
A company with a hold recommendation is expected to perform on par with comparable companies or in line with the market.
Also known as "moderate buy", "accumulate", and "overweight." Outperform is an analyst recommendation meaning a stock is expected to do slightly better than the market return.
Also known as strong buy and "on the recommended list." Needless to say, buy is a recommendation to purchase a specific security.
Also known as strong sell, it's a recommendation to sell a security or to liquidate an asset.
A recommendation that means a stock is expected to do slightly worse than the overall stock market return. Underperform can also be expressed as "moderate sell", "weak hold" and "underweight."
A company with a hold recommendation is expected to perform on par with comparable companies or in line with the market.
Also known as "moderate buy", "accumulate", and "overweight." Outperform is an analyst recommendation meaning a stock is expected to do slightly better than the market return.
Also known as strong buy and "on the recommended list." Needless to say, buy is a recommendation to purchase a specific security.
The company is engaged in the production and development of new drugs in the field of pharmaceuticals, surgery, regeneration, hardware and biological effects. The main activity of the company is in 4 areas: medical aesthetics (plastic surgery), gastroenterology, Central nervous system and eye care.
In medical aesthetics, various types of breast implants, tissue expanders, and corrective injectables are presented. Gastroenterology produces tablets, capsules, suspensions, injections and rectal suppositories for appropriate treatment of gastric pathologies. In the field of eye care, ophthalmic solutions, creams, and ointments are produced. Preparations for the nervous system are available in the form of injections, tablets, capsules containing both activating and soothing components.
As of 2017, most of Allergan's shares are held by institutional investors (the Vanguard Group, Wellington Management Group, BlackRock, State Street Corporation, Fidelity Investments, and others).